|
New
Users Click Here
If
you are a new user, please follow these
instructions: To take this course online, you
need to register, read the modules, take the
posttest exam, and pay for the course. To
begin, you will first need to register &
then you may log-in.
Returning
Users Click Here
If you
are a returning user & have already selected a User Name and
Password click above to continue your training.
Overview:
This course provides information regarding
the use of buprenorphine for the treatment
of opioid addiction. It reviews legislation
regarding office-based opioid-addiction
treatment, pharmacology, safety and
effectiveness, patient assessment and
selection, clinical management, special
treatment populations, dosing, urine
testing, and patient confidentiality. It
meets the 8-hour training requirement
specified in the Drug Addiction Treatment
Act of 2000 for physicians to qualify for
prescribing and dispensing buprenorphine in
their offices for the treatment of opioid
dependence. Users can take individual
modules or the entire 13-module, 9-hour
course.
Authors:
Eric Strain, M.D., Associate
Professor, Department of Psychiatry and
Behavioral Sciences, Johns Hopkins
University School of Medicine; Jeff Novey,
M.P.H., Senior Writer, Publications Services
Group, Social and Statistical Sciences,
Research Triangle Institute International.
Accreditation:
This course has been reviewed and is
acceptable for up to 9 prescribed credit
hours by the American Academy of Family
Physicians.
Registration
Fee:
AAAP
Members: $99
Non-members:
$189
Participants
have the option of taking selected modules
rather than the entire course to supplement
face-to-face training, refresh their memory
or review specific sections for additional
training. The fees for taking individual
modules are $11 per CME credit hour for AAAP
members and $21 per CME credit hour for
non-members.
This
course is sponsored by the American Academy
of Addiction Psychiatry (AAAP) and was
developed with funding from the Center for
Substance Abuse Treatment (CSAT).
|